$28.34
-0.17-0.6%
마지막 업데이트: Oct 13, 5:40 AM
$28.36
-0.15-0.53%
Benzinga
Benzinga
Benzinga
화요일, 10월 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Viking Therapeutics (VKTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.21 | $-0.92 | $-0.90 | $-0.68 |
| Actual | $-1.10 | $-1.37 | $-1.38 | $-0.81 |
| Surprise | +9.09% | -48.9% | -53.3% | -19.1% |
| Revenue | ||||
| Estimate | — | — | $10.0M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.05 | $-1.08 | $-0.85 | $-0.79 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-1.10 | $-1.21 | 9.09 % |
| Q1 | Apr 29, 2026 | $-1.37 | $-0.92 | -48.9 % |
| Q4 | Feb 11, 2026 | $-1.38 | $-0.90 | -53.3 % |
| Q3 | Oct 22, 2025 | $-0.81 | $-0.68 | -19.1 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q4 | Feb 11, 2026 | $0 | $10.00M | -100.0 % |